Search

everythinglearnresearchcommunity

for

Search:↓

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

A group has developed therapies that show promise for treating cancer and various other conditions.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Long COVID patients have more health issues than non-infected people.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

Hair cortisol may be a good indicator of recent mood in people with bipolar disorder.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Minoxidil effectively treats female pattern hair loss.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.